Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 14, 2026
Why Is Falcon's Beyond Global (FBYD) Stock Down -15.23% Today?

Why Is Falcon's Beyond Global (FBYD) Stock Down -15.23% Today?

Key Takeaways

  • FBYD shares plunged 15.23% to $11.08 in Tuesday's session, extending a brutal multi-day sell-off that has erased more than 40% of the stock's value from its July peak above $19.
  • The primary catalyst appears to be aggressive profit-taking following a meteoric rally that saw the stock surge over 200% year-over-year at its highs, combined with resurgent concerns about the company's financial health.
  • Secondary drivers include a technical breakdown below key moving averages, elevated trading volume signaling institutional distribution, and broader weakness across small-cap and experiential entertainment names.
  • The company's own SEC filings contain a going concern warning, and negative operating cash flow of $24.6 million over the trailing twelve months continues to weigh on investor sentiment.
  • Traders are now watching for any corporate announcements, insider buying activity, or stabilization around the $10 psychological level as potential signs of a bottom.

Opening Summary

FBYD, Falcon's Beyond Global, Inc., an Orlando-based experiential entertainment company that designs, develops, and operates themed attractions, resorts, and immersive experiences worldwide, saw its shares plummet 15.23% on Tuesday. The stock closed the previous session at $13.07 and tumbled to $11.08 in active trading, marking one of the steepest single-day declines for the small-cap conglomerate in recent months. The sell-off extends a punishing streak that has now wiped out the majority of gains accumulated during the stock's remarkable first-half rally, leaving investors scrambling for answers.

Profit-Taking After a Meteoric Rally

The most immediate driver behind FBYD's sharp decline is a classic case of profit-taking following an extraordinary run-up. The stock had surged more than 200% on a year-over-year basis at its July peak, fueled by enthusiasm around the company's first-quarter 2026 earnings report in May, which showed consolidated revenue of $5.4 million and a swing to net income of $6.1 million. The company also announced $18 million in new dark ride vehicle system agreements with VAI Amusement Park, bolstering the growth narrative. However, much of that reported net income stemmed from an $11.1 million credit for the reversal of accrued transaction expenses—a non-recurring item that flattered the bottom line. As the initial euphoria faded, traders began locking in profits, and the selling has cascaded into a full-blown correction.

Financial Health Concerns Resurface

Beneath the surface-level optimism generated by the Q1 earnings release, FBYD carries significant financial baggage that has come back into focus. The company's own SEC filings explicitly state that "current liquidity resources raise substantial doubt about our ability to continue as a going concern." Operating cash flow for the trailing twelve months stands at negative $24.6 million, and the company held just $1.18 million in cash and equivalents as of March 31, 2026, against $16.7 million in total debt. With a current ratio of 0.45, the company's short-term liquidity position remains precarious. As the broader market digests these figures, the risk-reward calculus has shifted dramatically, prompting investors to reassess the sustainability of the stock's elevated valuation.

Technical Breakdown Accelerates Selling Pressure

The velocity of FBYD's decline has been amplified by technical factors. The stock has sliced through its 50-day moving average, which had provided support during the rally phase, and is now approaching its 200-day moving average near $11.46. The breach of these key levels triggered stop-loss orders and algorithmic selling, compounding the downward momentum. Volume on Tuesday was significantly elevated relative to the average daily volume of approximately 102,000 shares, suggesting that institutional investors may be reducing positions. The stock's beta of -0.98 indicates an inverse relationship with broader market moves, but in this case, the selling has been indiscriminate and driven by stock-specific concerns rather than macro forces.

Broader Small-Cap and Sector Weakness

FBYD's decline is also occurring against a backdrop of softening sentiment in the small-cap space and the industrial conglomerates sector. The Russell 2000 index, which includes FBYD following its addition in late 2025, has shown signs of fatigue after a strong first-half performance. Experiential entertainment and theme park-related names have faced headwinds from lingering concerns about consumer discretionary spending and the pace of economic growth. While no single macro catalyst explains the magnitude of FBYD's drop, the combination of sector rotation away from high-beta small caps and profit-taking in momentum-driven names has created a challenging environment for the stock.

Trending AI Robots

In volatile market conditions like those affecting FBYD today, traders often turn to data-driven tools to navigate uncertainty. Tickeron's Trending AI Robots page offers a curated selection of the platform's top-performing AI-driven trading bots, drawn from a library of hundreds that actively analyze and trade thousands of tickers across diverse markets. These bots employ a range of strategies—including momentum, mean reversion, and pattern recognition—across short-term, swing, and long-term timeframes. Only the strongest performers under current market conditions are featured, with detailed metrics such as win rates, average returns, and drawdowns available for evaluation. For investors seeking to incorporate machine learning insights into their decision-making process, exploring the Trending AI Robots section can provide a valuable edge in identifying opportunities and managing risk.

What Comes Next for FBYD

Looking ahead, FBYD investors will be closely monitoring several key developments. The company's next earnings report is expected around August 13, 2026, and will be critical for assessing whether the operational momentum highlighted in Q1 is sustainable. Of particular importance will be updates on the $29.2 million contracted pipeline at Falcon's Creative Group, progress on the VAI dark ride agreements, and any improvement in the company's cash position. The company's ability to secure additional financing or strategic partnerships will also be under scrutiny given the going concern warning. On the technical side, the $10 level represents a psychological support zone, while any move back above the 200-day moving average could signal stabilization. Risks remain tilted to the downside, however, including potential dilution from warrant conversions, execution risks on large-scale projects, and the seasonal weakness in the PDP joint venture. Until the company demonstrates a clear path to sustainable positive cash flow, volatility is likely to persist.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FBYD

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


FBYD's RSI Oscillator recovers from oversold territory

The RSI Indicator for FBYD moved out of oversold territory on August 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In of the 14 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 32 cases where FBYD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FBYD just turned positive on August 07, 2026. Looking at past instances where FBYD's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBYD advanced for three days, in of 142 cases, the price rose further within the following month. The odds of a continued upward trend are .

FBYD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FBYD as a result. In of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

FBYD moved below its 50-day moving average on July 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FBYD crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBYD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FBYD entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FBYD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FBYD's P/B Ratio (32.895) is very high in comparison to the industry average of (6.519). P/E Ratio (55.556) is within average values for comparable stocks, (68.482). FBYD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.491). FBYD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). FBYD's P/S Ratio (22.727) is very high in comparison to the industry average of (2.694).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBYD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are 3M Company (NYSE:MMM), Honeywell International (NASDAQ:HON).

Industry description

Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).

Market Cap

The average market capitalization across the Industrial Conglomerates Industry is 7.46B. The market cap for tickers in the group ranges from 124.33K to 139.63B. HTHIY holds the highest valuation in this group at 139.63B. The lowest valued company is FSTF at 124.33K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Conglomerates Industry was 5%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 10%. PLAG experienced the highest price growth at 1,007%, while MATW experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Industrial Conglomerates Industry was 166%. For the same stocks of the Industry, the average monthly volume growth was 323% and the average quarterly volume growth was 703%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 55
Price Growth Rating: 53
SMR Rating: 73
Profit Risk Rating: 78
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
FBYD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry IndustrialConglomerates

Profile
Details
Industry
N/A
Address
1768 Park Center Drive
Phone
+1 407 909-9350
Employees
222
Web
https://www.falconsbeyond.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.